GSGorjan Stojanovski

Gorjan Stojanovski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gorjan Stojanovski has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mechanoenzymatic reactions for the hydrolysis of PET

    by Esther Ambrose-Dempster, Leona Leipold, Dragana Dobrijevic, Maria Bawn, Eve M. Carter, Gorjan Stojanovski, Tom D. Sheppard, Jack W. E. Jeffries, John M. Ward, Helen C. Hailes

    Mechanoenzymatic reactions are described for the degradation of different PET materials using whole cell PETases.


  • Open Access

    Facile and selective N -alkylation of gentamicin antibiotics via chemoenzymatic synthesis

    by Gorjan Stojanovski, Helen C. Hailes, John M. Ward

    The rise and spread of antimicrobial resistance has necessitated the development of novel antimicrobials which are effective against drug resistant pathogens. Aminoglycoside antibiotics (AGAs) remain one of our most effective classes of bactericidal drugs. However, they are challenging molecules to selectively modify by chemical synthesis, requiring the use of extensive protection and deprotection steps leading to long, atom- and step-inefficient synthetic routes. Biocatalytic and chemoenzymatic approaches for the generation of AGA derivatives are of interest as they allow access to more concise and sustainable synthetic routes to novel compounds. This work presents a two-step chemoenzymatic route to regioselectively modify the C-6′ position of AGAs. The approach uses a transaminase enzyme to generate an aldehyde on the C-6′ position in the absence of protecting groups, followed by reductive amination to introduce substituents selectively on this position. Seven candidate transaminases were tested for their ability to deaminate a panel of commercially available AGAs. The C-6′ transaminases could deaminate both pseudo di- and trisaccharide AGAs and tolerate the presence or absence of hydroxyl groups on the C-3′- and C-4′-positions. Additionally, sugar substituents on the C-6 hydroxyl were accepted but not on the C-5 hydroxyl. The most promising enzyme, GenB4, was then coupled with a reductive amination step to synthesise eleven novel 6′-gentamicin C1a analogues with conversions of 13–90%. Five of these compounds were active antimicrobials and four of these retained activity against an aminoglycoside-resistant Escherichia coli. This approach allows facile and step-efficient access to novel aminoglycoside compounds under mild reaction conditions and could potentially enable the development of greener, sustainable, and more cost-effective syntheses of novel AGAs.